Da Volterra attending BIO-Europe Spring in Vienna on March 25-27

04 March 2019

Da Volterra attending BIO-Europe Spring in Vienna on March 25-27

Back to news page

Da Volterra attending BIO-Europe Spring in Vienna on March 25-27

This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance segments to allow delegates to meet more key decision makers in three days of partnering meetings than they could in a whole year.

We look forward to sharing updates on DAV132 and meeting with both current and potential partners!

Do not hesitate to reach out to our Business Development team at bd@davolterra.com

Website Event link here

Latest news

events

12 December 2019

Da Volterra’s CEO, Florence Séjourné, and CBO, Pierre-Alain Bandinelli, are attending J.P. Morgan Healthcare Conference in SFO!

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together…

more

news

03 December 2019

Da Volterra Announces Positive Results of a Phase 1 Drug-Drug Interaction Study Demonstrating No Interaction Between DAV132 and Two Narrow Therapeutic Index Drugs

Paris (France), 3rd of December, 2019 – Da Volterra, a clinical-stage biopharmaceutical company developing innovative products to protect the intestinal…

more

events

31 October 2019

Da Volterra attending World Anti-Microbial Resistance Congress in Washington DC on November 07-08!

World Anti-Microbial Resistance Congress is the World largest AMR conference for all stakeholders combatting Anti-Microbial Resistance! The conference gathers global…

more